[1] 何林燕, 杨翠霞, 王文涓, 等. 肿瘤相关巨噬细胞诱导乳腺癌耐药的实验研究[J]. 检验医学, 2014, 29(9): 903. doi: 10.3969/j.issn.1673-8640.2014.09.008
[2] YANG C, HE L, HE P, et al. Increased drug resistance in breast cancer by tumor-associated macrophages through IL-10/STAT3/bcl-2 signaling pathway[J]. Med Oncol, 2015, 32(2): 352.
[3] IRELAND L, SANTOS A, AHMED MS, et al. Chemoresistance in pancreatic cancer is driven by stroma-derived insulin-like growth factors[J]. Cancer Res, 2016, 76(23): 6851. doi: 10.1158/0008-5472.CAN-16-1201
[4] MENG F, HENSON R, PATEL T. Chemotherapeutic stress selectively activates NF-κ B-dependent AKT and VEGF expression in liver cancer-derived endothelial cells[J]. Am J Physiol Cell Physiol, 2007, 293(2): C749. doi: 10.1152/ajpcell.00537.2006
[5] DOBBS JL, SHIN D, KRISHNAMURTHY S, et al. Confocal fluorescence microscopy to evaluate changes in adipocytes in the tumor microenvironment associated with invasive ductal carcinoma and ductal carcinoma in situ[J]. Int J Cancer, 2016, 139(5): 1140. doi: 10.1002/ijc.30160
[6] SUN Y, ZHU D, CHEN F, et al. SFRP2 augments WNT16B signaling to promote therapeutic resistance in the damaged tumor microenvironment[J]. Oncogene, 2016, 35(33): 4321. doi: 10.1038/onc.2015.494
[7] WEIGELT B, LO AT, PARK CC, et al. HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment[J]. Breast Cancer Res Treat, 2010, 122(1): 35. doi: 10.1007/s10549-009-0502-2
[8] 魏慧君, 郭丽丽, 李林, 等. Warburg效应及其对肿瘤转移的影响[J]. 中国肺癌杂志, 2015, 18(3): 179.
[9] KUMAR S, VAIDYA M. Hypoxia inhibits mesenchymal stem cell proliferation through HIF1α-dependent regulation of P27[J]. Mol Cell Biochem, 2016, 415(1/2): 29.
[10] ZHANG P, ZHOU H, LU K, , et al. Exosome-mediated delivery of MALAT1 induces cell proliferation in breast cancer[J]. Onco Targets Ther, 2018, 11(1): 291.
[11] OGATA-KAWATA H, IZUMIYA M, KURIOKA D, et al. Circulating exosomal microRNAs as biomarkers of colon cancer[J]. PLoS One, 2014, 9(4): e92921. doi: 10.1371/journal.pone.0092921
[12] NUSRAT O, BELOTTE J, FLETCHER NM, et al. The role of angiogenesis in the persistence of chemoresistance in epithelial ovarian cancer[J]. Reprod Sci, 2016, 23(11): 1484. doi: 10.1177/1933719116645191
[13] ZHANG L, LV Z, XU J, et al. MicroRNA-134 inhibits osteosarcoma angiogenesis and proliferation by targeting the VEGFA/VEGFR1 pathway[J]. FEBS J, 2018, 285(7): 1359. doi: 10.1111/febs.14416
[14] TU Y, LIU L, ZHAO D, et al. Overexpression of miRNA-497 inhibits tumor angiogenesis by targeting VEGFR2[J]. Sci Rep, 2015, 5(1): 13827. doi: 10.1038/srep13827
[15] VELICEASA D, BIYASHEV D, QIN G, et al. Therapeutic manipulation of angiogenesis with miR-27b[J]. Vasc Cell, 2015, 7: 6. doi: 10.1186/s13221-015-0031-1
[16] 黄庆波. 血管内皮特异性因子DLL4在肾细胞癌肿瘤生长, 侵袭, 血管生成及血行转移中的作用[D]. 兰州: 兰州大学, 2015.
[17] BIAN EB, CHEN EF, XU YD, et al. Exosomal lncRNAATB activates astrocytes that promote glioma cell invasion[J]. Int J Oncol, 2019, 54(2): 713.
[18] ZHOU Y, XIA L, LIN J, et al. Exosomes in nasopharyngeal carcinoma[J]. J Cancer, 2018, 9(5): 767. doi: 10.7150/jca.22505
[19] LIU L, MENG T, YANG XH, et al. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion[J]. Cancer Biomark, 2018, 22(2): 283. doi: 10.3233/CBM-171011
[20] LIU C, LIU L, CHEN X, et al. LSD1 Stimulates cancer-associated fibroblasts to drive notch3-dependent self-renewal of liver cancer stem-like cells[J]. Cancer Res, 2018, 78(4): 938. doi: 10.1158/0008-5472.CAN-17-1236